Skip to Content

Notice

Advisory Committee to the Director, Centers for Disease Control and Prevention-Health Disparities Subcommittee

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 1379

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned subcommittee:

Time and Date: 10:00 a.m.-12:00 p.m. EDT, February 13, 2014.

Place: Teleconference.

Status: This meeting is open to the public, limited only by the availability of telephone ports. The public is welcome to participate during the public comment period, which is tentatively scheduled from 11:45 a.m. to 11:55 a.m. To participate on the teleconference, please dial (866) 763-0273 and enter code 6158968.

Purpose: The Subcommittee will provide advice to the CDC Director through the Advisory Committee to the Director (ACD) on strategic and other health disparities and health equity issues and provide guidance on opportunities for CDC.

Matters To Be Discussed: The Health Disparities Subcommittee (HSD) members will discuss some of the current health equity activities at CDC, as well as discuss health equity recommendations to the CDC ACD.

The agenda is subject to change as priorities dictate.

Contact Person for More Information: Leandris Liburd, Ph.D., M.P.H., M.A., Designated Federal Officer, Health Disparities Subcommittee, ACD, CDC, 1600 Clifton Road NE., M/S K-77, Atlanta, Georgia 30333, Telephone (770) 488-8182, Email: LEL1@cdc.gov.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Gary J. Johnson,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. 2014-00043 Filed 1-7-14; 8:45 am]

BILLING CODE 4163-18-P